which is safer tirzepatide or semaglutide Obesity Troubling Findings in Study of

Slowing Gastric Emptying : By delaying the movement of food from the stomach to the intestines, GLP-1 medications enhance feelings of fullness and satiety, which can help reduce food intake

The major difference is molecular structure: orforglipron is a non-peptide small molecule that survives digestion, while semaglutide is peptide-based and requires injection

The clinical effects are determined by semaglutide, which is identical across all versions

The changes that matter most: California, New Hampshire, Pennsylvania, and South Carolina all eliminated weight loss GLP-1 coverage for adults effective January 1, 2026